Company Data

Achilles Therapeutics plc

Ticker
ACHL
Current Price
$1.185 -0.42%
Market Cap
$48.7M
Price Target
Refer to Report
Volume
279.0K
52wk Range
$0.63 - $1.76
Advanced Market Data

Overview

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy